Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicaid AMP lawsuit delayed

Executive Summary

A lawsuit seeking to block CMS from implementing a rule that would reimburse pharmacies 250 percent of the average manufacturer price for the least expensive drug in a multi-source group has been delayed because of the change of administration in the White House. The National Association of Chain Drug Stores, the National Community Pharmacists Association (who brought the original suit to keep the regulations from going into effect) and HHS requested the delay since CMS has yet to resolve any regulatory issues related to the definition of "multiple source drug." A hearing on the case had been scheduled for Feb. 25. Participants in the case do not expect action until at least the middle of May. A judge in the case granted a temporary injunction to prevent the rule from going into effect (1"The Pink Sheet," Dec. 17, 2007, In Brief). The Medicare Improvements for Patients and Providers Act delayed implementation of the rule through Sept. 30, 2009 (2"The Pink Sheet," July 21, 2008, p. 21). During the debate on the economic stimulus package in the Senate, Sens. Blanche Lincoln, D-Ark., and Debbie Stabenow, D-Mich., introduced an amendment that would have extended the delay through June 30, 2010, but no action was taken
Advertisement

Related Content

Medicaid holiday cheer for pharmacy

Topics

Advertisement
UsernamePublicRestriction

Register

PS050727

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel